Key result
DMD mutation carrier manifests asymptomatic hyperCKemia and psychiatric problems, highlighting the need for cognitive monitoring.
Case Report (n=1)
Female carriers of DMD mutations may manifest psychiatric and cognitive problems due to dystrophin deficit, even in the absence of severe physical symptoms.
Answers are grounded in this paper and cite their sources.
May expand dystrophinopathy phenotype to include isolated psychiatric features; leaves open whether targeted screening or testing is warranted.
We report the case of a 64‐year‐old woman with dystrophinopathy exhibiting asymptomatic hyperCKemia and psychiatric symptoms only. Since adolescence, she had experienced communication difficulties and anxiety neurosis, which kept her unemployed and once led her to attempt suicide. Her full intelligence quotient was 89, with relatively low scores in processing speed and working memory, because of attention/concentration deficit or obsession. She has a nephew with severe dystrophinopathy, and both of them had duplication of exon 44 of the DMD gene, encoding dystrophin. Her mother became wheelchair user at age 60, and was suspected to have some psychiatric problems since she neglected her own ailing child. The cognitive and mental states of women with dystrophinopathy should be paid more attention to since such problems may manifest due to dystrophin deficit.
No takes yet. Share an insight, caveat, or question.
Kaido et al. (2018) conducted a case report in Dystrophinopathy (DMD mutation carrier) (n=1). DMD mutation (duplication of exon 44) was evaluated on Clinical presentation (asymptomatic hyperCKemia and psychiatric symptoms). A 64-year-old female carrier with a DMD mutation (duplication of exon 44) manifested asymptomatic hyperCKemia and psychiatric problems, highlighting the need to monitor cognitive and mental states.
Synapse has enriched 10 related papers. Consider them for comparative context: